Press Release | December 12, 2022
Orchard Therapeutics Announces Promising Early Neurocognitive Outcomes from Ongoing Proof-of-concept Study of OTL-201 in MPS-IIIA
Read More
Press Release | December 12, 2022
Freenome Presents Research Highlighting The Promise of Identifying Drug-Response Biomarker for DLBCL Patients
Read More
Press Release | December 8, 2022
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
Read More
Press Release | December 8, 2022
Dragonfly Therapeutics Announces First Patient Dosed in Phase 1 Study of its EGFR-targeting TriNKET™
Read More
